The transplant programs at NewYork-Presbyterian rank among the best in the nation for volume and survival. Specialists from Columbia and Weill Cornell Medicine lead the field in medical and surgical management of transplant patients, expanding access to lifesaving procedures and improving patient outcomes. In 2025, teams across the institution achieved remarkable milestones, including performing New York’s first heart-lung-liver and fully robotic liver transplant surgeries; developing noninvasive methods to monitor graft rejection in pediatric patients; and successfully treating multiple pediatric and adult patients through innovative domino procedures. These achievements reflect our steadfast commitment to advancing treatment for all patients.
The transplant program at NewYork-Presbyterian, Columbia, and Weill Cornell Medicine is among the longest established and most experienced program in the country. Due to their experience and expertise, our physicians can confidently care for some of the most complex transplants, including multi-organ transplants. Patients come to us from across the country and around the world for better outcomes and innovative procedures that allow for quicker access to transplants and also quicker recovery.
Transplant
Stay up to date with the latest in Transplant medicine
The NYP Advances newsletter delivers groundbreaking research and advancements straight to your inbox.
Featured Updates
On this episode of Advances in Care, Dr. Steven Lobritto, pediatric medical director for liver transplant at NewYork-Presbyterian and Columbia, joins host Erin Welsh to tell the story of a high-risk pediatric liver transplant that he and his team performed to save the life of a two month old baby, after the center where the baby was originally treated deemed her inoperable.
The Latest
Stay up to date with the Advances newsletter
Get the latest groundbreaking research and advancements in medicine delivered to your inbox.
